Life Sciences Go-to-Market Coverage Study

The future of life sciences and analytical instruments will be shaped by digital technology enhancements, generative AI, faster innovation, a focus on customer experience, reliance on scientific specialists and a strong revenue operations team to tie it all together. With these adjustments, to remain profitable in an increasingly competitive market, industry leaders are reprioritizing their go-to-market coverage models.

Join Alexander Group’s Life Sciences Go-to-Market Coverage Study to share your perspectives on the following topics:

• Maximize Go-to-Market Investments: As many companies are making GTM model investments to achieve sustainable growth, what are you investing in over the next 3-5 years?
• Customer Expectations & Evolving Coverage Models: How are emerging customer needs and pain points prompting you to adjust your current coverage model? How much do you see coverage models evolving over the next 2-3 years?
• Adapting to the Age of AI: As AI is rapidly transforming the sales landscape, how do you anticipate AI to evolve role responsibilities and coverage models? Which roles do you expect will be most/least impacted by AI?
• Commercial Strategy: What do you believe is your biggest commercial challenge for 2024?

Participation consists of a short interview to gain your insights on these topics. Upon completion, we will provide you with a full report of the study findings along with a complimentary readout. There is no cost to participate, and all information is shared only in aggregate.

Determine the best GTM coverage strategies and investments—participate today!

If interested, please complete the form and a Life Sciences practice lead will be in touch with you for a 30-minute introductory call.

Participate »